First-in-human (FIH) phase I data of HST-1011, an oral CBL-B inhibitor, in patients with advanced solid tumors

Publication Title

ESMO Congress; 2024 September 13; Barcelona, Spain

Document Type

Presentation

Publication Date

9-1-2024

Keywords

washington; spokane; pmrc

Area of Special Interest

Cancer

Specialty/Research Institute

Oncology

This document is currently not available here.


Share

COinS